A final common pathway for depression? Progress toward a general conceptual framework

Abstract

Functional neuroimaging studies of depressed patients have converged with functional brain mapping studies of depressed animals in showing that depression is accompanied by a hypoactivity of brain regions involved in positively motivated behavior together with a hyperactivity in regions involved in stress responses. Both sets of changes are reversed by diverse antidepressant treatments. It has been proposed that this neural pattern underlies the symptoms common to most forms of the depression, which are the loss of positively motivated behavior and increased stress. The paper discusses how this framework can organize diverse findings ranging from effects of monoamine neurotransmitters, cytokines, corticosteroids and neurotrophins on depression. The hypothesis leads to new insights concerning the relationship between the prolonged inactivity of the positive motivational network during a depressive episode and the loss of neurotrophic support, the potential antidepressant action of corticosteroid treatment, and to the key question of whether antidepressants act by inhibiting the activity of the stress network or by enhancing the activity of the positive motivational system. Keywords depression; neuroimaging; fos; final common pathway; cytokines; corticosteroids; monoamines; neurotrophins; theory The quest for a final common pathway has long been goal of research in depression. Famous candidates in this search have included dysregulated brain monoamines (Schildkraut, 1965;

Effects of stress, depression, and their interaction on heart rate, skin conductance, finger temperature, and respiratory rate: sympathetic‐parasympathetic hypothesis of stress and depression

“…(b) Depression initially associates with the sympathetic division and then shifts to involve the parasympathetic division. This phenomenon is hypothesized to be parallel to sever major depression patients who might suffer from less motivation and hypoactivity in motor functions during the late developmental depression stage (Kalueff, Gallagher, & Murphy, 2006;Stone, Lin, & Quartermain, 2008). However, on the early stage of depression, depression patients under a stress condition just respond to the sympathetic activity.…”

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

“…26,27 When apathy coexists with depression, reduction in motivated behaviours is associated with a dysfunctional network that is shown by hyperactivity of the subgenual cingulate cortex (BA25), and hypometabolism of both the dorsolateral prefrontal cortex and the dorsal anterior cingulate cortex (BA24b). [28][29][30] With recovery from depression, metabolism in the dorsal anterior cingulate cortex is restored and goal-directed behaviours improve. 31,32 Apathy in the context of executive dysfunction is related to decreased activity in a network that encompasses the dorsolateral prefrontal cortex, lateral aspects of the caudate nucleus and putamen, the anterior cingulate cortex, and the posterior parietal cortex.…”

A model for continuous monitoring of patients with major depression in short and long term periods

“…Before going through the description of the PAU it is necessary to briefly describe major depression characteristics. It is now generally recognized that depression is a multifactor disorder characterized by phenotypic heterogeneity and having complex genetic, experiential, and developmental causes [32].…”